157 related articles for article (PubMed ID: 29937938)
1. Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin.
Ma Q; Feng Y; Deng K; Shao H; Sui T; Zhang X; Sun X; Jin L; Ma Z; Luo G
J Cancer; 2018; 9(12):2183-2190. PubMed ID: 29937938
[TBL] [Abstract][Full Text] [Related]
2. The Inhibition of Serine/Threonine Protein Phosphatase Type 5 Mediates Cantharidin Toxicity to Control
Sun H; Li Y; Li X; Zhang Y
Insects; 2020 Oct; 11(10):. PubMed ID: 33050059
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin.
Liu Q; Sun H; Li X; Sheng H; Zhu L
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431851
[TBL] [Abstract][Full Text] [Related]
4. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB
J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response.
Yan J; Deng XL; Ma SQ; Hui Li Y; Gao YM; Shi GT; Wang HS
BMC Complement Med Ther; 2023 May; 23(1):160. PubMed ID: 37202806
[TBL] [Abstract][Full Text] [Related]
6. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
Ren J; Li G; Zhao W; Lin L; Ye T
World J Gastroenterol; 2016 Apr; 22(15):3962-8. PubMed ID: 27099439
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin modulates development of dendritic cells and prolongs skin allograft survival.
Hsieh CH; Liao HF; Kuo CD; Huang YC; Shueng PW; Hsu YP; Wang LY; Tsai TH; Chen YJ
Transplantation; 2011 Oct; 92(8):848-57. PubMed ID: 21876479
[TBL] [Abstract][Full Text] [Related]
9. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells.
Chen YJ; Chang WM; Liu YW; Lee CY; Jang YH; Kuo CD; Liao HF
Chem Biol Interact; 2009 Oct; 181(3):440-6. PubMed ID: 19616522
[TBL] [Abstract][Full Text] [Related]
10. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
11. Cantharidin impairs cell migration and invasion of A375.S2 human melanoma cells by suppressing MMP-2 and -9 through PI3K/NF-κB signaling pathways.
Ji BC; Hsiao YP; Tsai CH; Chang SJ; Hsu SC; Liu HC; Huang YP; Lien JC; Chung JG
Anticancer Res; 2015 Feb; 35(2):729-38. PubMed ID: 25667452
[TBL] [Abstract][Full Text] [Related]
12. Medical uses of mylabris in ancient China and recent studies.
Wang GS
J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797
[TBL] [Abstract][Full Text] [Related]
13. Norcantharidin alone or in combination with crizotinib induces autophagic cell death in hepatocellular carcinoma by repressing c-Met-mTOR signaling.
Sun CY; Zhu Y; Li XF; Tang LP; Su ZQ; Wang XQ; Li CY; Yang HM; Zheng GJ; Feng B
Oncotarget; 2017 Dec; 8(70):114945-114955. PubMed ID: 29383132
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes.
Kok SH; Hong CY; Kuo MY; Lee CH; Lee JJ; Lou IU; Lee MS; Hsiao M; Lin SK
Oral Oncol; 2003 Jan; 39(1):19-26. PubMed ID: 12457717
[TBL] [Abstract][Full Text] [Related]
15. Review targeted drug delivery systems for norcantharidin in cancer therapy.
Zhai BT; Sun J; Shi YJ; Zhang XF; Zou JB; Cheng JX; Fan Y; Guo DY; Tian H
J Nanobiotechnology; 2022 Dec; 20(1):509. PubMed ID: 36463199
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.
Zheng LC; Yang MD; Kuo CL; Lin CH; Fan MJ; Chou YC; Lu HF; Huang WW; Peng SF; Chung JG
Anticancer Res; 2016 Nov; 36(11):6031-6042. PubMed ID: 27793930
[TBL] [Abstract][Full Text] [Related]
17. Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways.
Hsia TC; Yu CC; Hsu SC; Tang NY; Lu HF; Huang YP; Wu SH; Lin JG; Chung JG
Int J Oncol; 2014 Jul; 45(1):245-54. PubMed ID: 24818581
[TBL] [Abstract][Full Text] [Related]
18. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.
Hong KO; Ahn CH; Yang IH; Han JM; Shin JA; Cho SD; Hong SD
Molecules; 2019 May; 24(10):. PubMed ID: 31109130
[TBL] [Abstract][Full Text] [Related]
19. Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma.
Hu MH; Huang TT; Chao TI; Chen LJ; Chen YL; Tsai MH; Liu CY; Kao JH; Chen KF
Liver Int; 2018 Dec; 38(12):2248-2259. PubMed ID: 29797403
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin, derivative of cantharidin, for cancer stem cells.
Hsieh CH; Chao KS; Liao HF; Chen YJ
Evid Based Complement Alternat Med; 2013; 2013():838651. PubMed ID: 24073010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
